Skip to main content
SpringerLink
Log in

Surgical Treatment of Prostate Cancer

  • Chapter
Urological Cancers in Clinical Practice

  • 358 Accesses

Abstract

Surgery for prostate cancer has evolved, with the main purpose of curing one of the most common male malignancies at an early stage in its natural history, and preventing the morbidity otherwise associated with unchecked disease progression to more advanced, incurable stages. The operation by which this may be achieved, radical prostatectomy, advanced considerably during the 20th century through developments in anatomical knowledge and surgical experience. It is now a routine surgical procedure in urological oncology carried out through a range of surgical approaches, each with its own advantages and disadvantages.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Young HH. The early diagnosis and radical cure of carcinoma of the prostate: being a study of 40 cases and presentation of a radical operation which was carried out in four cases. Johns Hopkins Hosp Bull 1905;16:315–321.

    Google Scholar 

  2. Young HH, Davis DM. Neoplasms of the urogenital tract. In: Young’s Practice of Urology. Philadelphia: WB Saunders, 1926;653–654.

    Google Scholar 

  3. Millin T. Retropubic prostatectomy: a new extravesical technique report on 20 cases. Lancet 1945;693–696.

    Google Scholar 

  4. Reiner WG, Walsh PC. An anatomical approach to the surgical management of the dorsal vein and Santorini’s plexus during radical retropubic surgery. J Urol 1979;121(2):198–200.

    PubMed  CAS  Google Scholar 

  5. Walsh PC, Donker PJ. Impotence following radical prostatectomy: insight into etiology and prevention. J Urol 1982;128(3):492–497.

    PubMed  CAS  Google Scholar 

  6. Walsh PC, Lepor H, Eggleston JC.Radical prostatectomy with preservation of sexual function: anatomical and pathological considerations. Prostate 1983;4(5):473–485.

    Article  PubMed  CAS  Google Scholar 

  7. Lepor H, Gregerman M, Crosby R, Mostofi FK, Walsh PC. Precise localization of the autonomic nerves from the pelvic plexus to the corpora cavernosa: a detailed anatomical study of the adult male pelvis. J Urol 1985;133:207–212.

    PubMed  CAS  Google Scholar 

  8. Walsh PC.Anatomic radical prostatectomy: evolution of the surgical technique. J Urol 1998;160:2418–2424.

    Google Scholar 

  9. Walsh PC, Epstein JI, Lowe FC. Potency following radical prostatectomy with wide unilateral excision of the neurovascular bundle. J Urol 1987;138(4):823–827.

    PubMed  CAS  Google Scholar 

  10. Schuessler WW, Kavoussi LR, Clayman RV, Vancaille TH. Laparoscopic radical prostatectomy: initial case report. J Urol 1992;147(4):246.

    Google Scholar 

  11. Schuessler WW, Schulam PG, Clayman RV, Kavoussi LR. Laparoscopic radical prostatectomy: initial short-term experience. Urology 1997;50(6):854–857.

    Article  PubMed  CAS  Google Scholar 

  12. Cadeddu JA, Kavoussi LR. Laparoscopic radical prostatectomy: is it feasible and reasonable? Urol Clin North Am 2001;28(3):655–661.

    Article  PubMed  CAS  Google Scholar 

  13. Guillonneau B, Vallancien G. Laparoscopic radical prostatectomy: the Montsouris experience. J Urol 2000;163(2):418–422.

    Article  PubMed  CAS  Google Scholar 

  14. Bollens R, Roumeguere T, Vanden Bossche M, Quackels T, Zlotta AR, Schulman CC. Comparison of laparoscopic radical prostatectomy techniques. Curr Urol Rep 2002;3(2):148–151.

    PubMed  Google Scholar 

  15. Guillonneau B, Cappele O, Martinez JB, Navarra S, Vallancien G. Robotic assisted, laparoscopic pelvic lymph node dissection in humans. J Urol 2001;165(4):1078–1081.

    Article  PubMed  CAS  Google Scholar 

  16. Abbou CC, Hoznek A, Salomon L, et al. Laparoscopic radical prostatectomy with a remote controlled robot. J Urol 2001;165(6 pt 1):1964–1966.

    PubMed  CAS  Google Scholar 

  17. Prasad SM, Maniar HS, Soper NJ, Damiano RJJ, Klingensmith ME. The effect of robotic assistance on learning curves for basic laparoscopic skills. Am J Surg 2002;183(6):702–707.

    Article  PubMed  Google Scholar 

  18. Stolzenburg JU, Truss MC. Technique of laparoscopic (endoscopic) radical prostatectomy. BJU Int 2003;91(8):749–757.

    Article  PubMed  Google Scholar 

  19. Menon M. Robotic radical retropubic prostatectomy. BJU Int 2003;91(3):175–176.

    Article  PubMed  CAS  Google Scholar 

  20. Han M, Partin AW, Pound CR, Epstein JI, Walsh PC. Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience. Urol Clin North Am 2001;28(3):555–565.

    Article  PubMed  CAS  Google Scholar 

  21. Jewett HJ, Bridge RW, Gray GFJ, Shelley WM. The palpable nodule of prostatic cancer. Results 15 years after radical excision. JAMA 1968;203(6):403–406.

    Article  PubMed  CAS  Google Scholar 

  22. Walsh PC. Radical prostatectomy, preservation of sexual function, cancer control. The controversy. Urol Clin North Am 1987;14(4):663–673.

    PubMed  CAS  Google Scholar 

  23. Han M, Partin AW, Piantadosi S, Epstein JI, Walsh PC. Era specific biochemical recurrence-free survival following radical prostatectomy for clinically localized prostate cancer. J Urol 2001;166(2):416–419.

    Article  PubMed  CAS  Google Scholar 

  24. Han M, Partin AW, Zahurak M, Piantadosi S, Epstein JI, Walsh PC. Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer. J Urol 2003;169(2):517–523.

    Article  PubMed  Google Scholar 

  25. Partin AW, Mangold LA, Lamm DM, Walsh PC, Epstein JI, Pearson JD. Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium. Urology 2001;58(6):843–848.

    Article  PubMed  CAS  Google Scholar 

  26. Khan MA, Han M, Partin AW, Epstein JI, Walsh PC. Long-term cancer control of radical prostatectomy in men younger than 50 years of age: update 2003. Urology 2003;62(1):86–91.

    Article  PubMed  Google Scholar 

  27. Carter HB, Epstein JI, Partin AW. Influence of age and prostate-specific antigen on the chance of curable prostate cancer among men with nonpalpable disease. Urology 1999;53(1):126–130.

    Article  PubMed  CAS  Google Scholar 

  28. Pound CR, Partin AW, Eisenberger MA, Chan DW, Pearson JD, Walsh PC. Natural history of progression after PSA elevation following radical prostatectomy. JAMA 1999;281(17):1591–1597.

    Article  PubMed  CAS  Google Scholar 

  29. Partin AW, Borland RN, Epstein JI, Brendler CB. Influence of wide excision of the neurovascular bundle(s) on prognosis in men with clinically localized prostate cancer with established capsular penetration. J Urol 1993;150(1):142–146.

    PubMed  CAS  Google Scholar 

  30. Smith RC, Partin AW, Epstein JI, Brendler CB. Extended followup of the influence of wide excision of the neurovascular bundle(s) on prognosis in men with clinically localized prostate cancer and extensive capsular perforation. J Urol 1996;156(2 pt 1):454–457.

    PubMed  CAS  Google Scholar 

  31. Shah O, Robbins DA, Melamed J, Lepor H. The New York University nerve sparing algorithm decreases the rate of positive surgical margins following radical retropubic prostatectomy. J Urol 2003;169(6):2147–2152.

    Article  PubMed  Google Scholar 

  32. Walsh PC. Anatomic radical retropubic prostatectomy. In: Walsh PC, Retik AB, Vaughan ED, Wein AJ, eds. Campbell’s Urology. Philadelphia: WB Saunders 2002;3107–3129.

    Google Scholar 

  33. de Koning HJ, Auvinen A, Berenguer SA, et al. Large-scale randomized prostate cancer screening trials: program performances in the European Randomized Screening for Prostate Cancer trial and the Prostate, Lung, Colorectal and Ovary Cancer Trial. Int J Cancer 2002;97(2):237–244.

    Article  PubMed  Google Scholar 

  34. Donovan J, Mills N, Smith M, et al. Quality improvement report: Improving design and conduct of randomised trials by embedding them in qualitative research: Protect (prostate testing for cancer and treatment) study. Commentary: presenting unbiased information to patients can be difficult. BMJ 2002;325:766–770.

    Article  PubMed  Google Scholar 

  35. Holmberg L, Bill-Axelson A, Helgesen F, et al. A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer. N Engl J Med 2002;347(11):781–789.

    Article  PubMed  Google Scholar 

  36. Stanford JL, Feng Z, Hamilton AS, et al. Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: the Prostate Cancer Outcomes Study. JAMA 2000;283(3):354–360.

    Article  PubMed  CAS  Google Scholar 

  37. Talcott JA, Rieker P, Propert KJ, et al. Patient-reported impotence and incontinence after nerve-sparing radical prostatectomy. J Natl Cancer Inst 1997;89(15):1117–1123.

    Article  PubMed  CAS  Google Scholar 

  38. Holzbeierlein J, Peterson M, Smith JA Jr. Variability of results of cavernous nerve stimulation during radical prostatectomy. J Urol 2001;165(1):108–110.

    Article  PubMed  CAS  Google Scholar 

  39. Walsh PC, Marschke P, Catalona WJ, et al. Efficacy of first-generation Cavermap to verify location and function of cavernous nerves during radical prostatectomy: a multi-institutional evaluation by experienced surgeons. Urology 2001;57(3):491–494.

    Article  PubMed  CAS  Google Scholar 

  40. Walsh PC, Marschke P, Ricker D, Burnett AL. Use of intraoperative video documentation to improve sexual function after radical retropubic prostatectomy. Urology 2000;55(1):62–67.

    Article  PubMed  CAS  Google Scholar 

  41. Kim ED, Nath R, Slawin KM, Kadmon D, Miles BJ, Scardino PT. Bilateral nerve grafting during radical retropubic prostatectomy: extended follow-up. Urology 2001;58(6):983–987.

    Article  PubMed  CAS  Google Scholar 

  42. Fowler FJ, Roman A, Barry MJ, Wasson J, Lu-Yao G, Wennberg JE. Patient-reported complications and follow-up treatment after radical prostatectomy: the national Medicare experience: 1988–1990 (updated June 1993). Urology 1993;42:622–629.

    Article  PubMed  Google Scholar 

  43. Talcott JA, Rieker P, Clark JA, et al. Patient-reported symptoms after primary therapy for early prostate cancer: results of a prospective cohort study. J Clin Oncol 1998;16(1):275–283.

    PubMed  CAS  Google Scholar 

  44. Heathcote PS, Mactaggart PN, Boston RJ, James AN, Thompson LC, Nicol DL. Health-related quality of life in Australian men remaining disease-free after radical prostatectomy. Med J Aust 1998;168(10):483–486.

    PubMed  CAS  Google Scholar 

  45. Catalona WJ, Carvalhal GF, Mager DE, Smith DS. Potency, continence and complication rates in 1,870 consecutive radical retropubic prostatectomies. J Urol 1999;162(2):433–438.

    Article  PubMed  CAS  Google Scholar 

  46. Rabbani F, Stapleton AM, Kattan MW, Wheeler TM, Scardino PT. Factors predicting recovery of erections after radical prostatectomy. J Urol 2000;164(6):1929–1934.

    Article  PubMed  CAS  Google Scholar 

  47. Walsh PC, Marschke P, Ricker D, Burnett AL. Patient-reported urinary continence and sexual function after anatomic radical prostatectomy. Urology 2000;55(1):58–61.

    Article  PubMed  CAS  Google Scholar 

  48. Begg CB, Riedel ER, Bach PB, et al. Variations in morbidity after radical prostatectomy. N Engl J Med 2002;346(15):1138–1144.

    Article  PubMed  Google Scholar 

  49. Eastham JA, Kattan MW, Riedel E, et al.Variations among individual surgeons in the rate of positive surgical margins in radical prostatectomy specimens. J Urol 2003;170(6 pt 1):2292–2295.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Urology and Nephrology, University College London and UCLH, Foundation Trust, London, UK

    Mark R. Feneley MD, FRCS

  2. The Prostate Centre, London, UK

    Roger S. Kirby MA, MD, FRCS

Authors
  1. Mark R. Feneley MD, FRCS
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Roger S. Kirby MA, MD, FRCS
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Oncology, Division of Surgery, Oncology Reproductive Biology and Anaesthetics (SORA), Faculty of Medicine, Imperial College London, The Garry Weston Centre, Hammersmith Hospital, London, UK

    Jonathan Waxman BSc, MD, FRCP (Professor of Oncology) (Professor of Oncology)

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer-Verlag London Limited

About this chapter

Cite this chapter

Feneley, M.R., Kirby, R.S. (2007). Surgical Treatment of Prostate Cancer. In: Waxman, J. (eds) Urological Cancers in Clinical Practice. Springer, London. https://doi.org/10.1007/978-1-84628-507-3_2

Download citation

  • DOI: https://doi.org/10.1007/978-1-84628-507-3_2

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-84628-464-9

  • Online ISBN: 978-1-84628-507-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation